Researchers move closer to cocaine vaccine

01/1/2008 | Houston Chronicle (tiered subscription model)

U.S. researchers are developing a vaccine to treat people with cocaine addiction. The vaccine aims to stimulate the immune system to recognize the drug and create antibodies to bind with the cocaine and prevent it from reaching the brain. The researchers are awaiting FDA approval to begin a multi-institutional trial.

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX